Litcius/Paper detail

Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study

Ossama Hamdy Salman, Hatem Saber Ail Mohamed

2020Egyptian Journal of Anaesthesia23 citationsDOIOpen Access PDF

Abstract

Background COVID-19 is highly contagious, potentially deadly current pandemic with no evidence-based cure or vaccines. The efficacy and safety of transfusion plasma of recovered patients were tested to treat patients with severe infection.

Topics & Concepts

MedicineFerritinCoronavirus disease 2019 (COVID-19)Internal medicineAntibodyGastroenterologyRandomized controlled trialFraction of inspired oxygenAnesthesiaImmunologyMechanical ventilationInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchErythrocyte Function and Pathophysiology
Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study | Litcius